Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
Randomized, placebo-controlled parallel trial (n=35) testing a single oral dose of ayahuasca versus placebo in patients with treatment-resistant major depression.
Detailed Description
This randomized, parallel-group trial evaluated the antidepressant effects of a single oral dose of ayahuasca compared with a passive placebo in patients with treatment-resistant major depression (n=35), with acute and longer-term follow-up.
Outcomes included depressive symptom scales (HAM-D, MADRS), psychiatric and neuropsychological assessments, MRI (structural and functional), polysomnography, and serum biomarkers (BDNF, TNF-α, cortisol, IL-6, IL-10).
Study Protocol
Preparation
Dosing
Integration
Study Arms & Interventions
Ayahuasca
experimentalSingle-dose ayahuasca treatment arm.
Interventions
- Ayahuascavia Oral• single dose• 1 doses total
Single dosing session; traditional ayahuasca decoction (Psychotria viridis + Banisteriopsis caapi).
Placebo
inactivePassive inert placebo comparator.
Interventions
- Placebovia Oral• single dose• 1 doses total
Single-dose passive placebo.
Participants
Inclusion Criteria
- Inclusion Criteria:
- Age: 18-60 years old;
- Diagnostic of major depressive disorder (DSM-IV);
- At least two previous unsuccessful antidepressant medications;
- Current depressive episode (HAM-D >= 17).
Exclusion Criteria
- Exclusion Criteria:
- History of psychosis;
- Present or past history of bipolar disorder or schizophrenia;
- Diagnosis of current clinical disease, based on history, physical examination and routine hematologic and biochemical tests;
- Serious and imminent suicidal risk;
- Pregnancy, current drug or alcohol dependence;
- Previous experience with ayahuasca.
Study Details
- StatusCompleted
- PhasePhase IPhase II
- Typeinterventional
- DesignRandomizedtriple Blind
- Target Enrollment35 participants
- TimelineStart: 2014-02-01End: 2016-12-01
- Compounds
- Topic